Regulators will tighten eligibility criteria for weight loss jabs such as Wegovy and Ozempic in a crackdown on inappropriate ...

Within 1 year, a single institution saw four patients with MSSA infections who developed AKI that was most likely secondary to nafcillin-associated AIN. Records from the institution show that ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

这项由圣路易斯退伍军人事务部医疗保健系统（Veterans Affairs St. Louis Health Care System）的研究人员主导的研究发现，这些GLP-1类药物可以降低多种健康问题的风险，包括药物滥用障碍、自杀倾向、精神分裂症和其他精神病性障碍等。研究还发现，这些药物能降低神经认知障碍（如阿尔茨海默病和老年痴呆）、感染、肝癌，甚至是威胁生命的血栓性疾病（如肺部血栓）的风险。

Objective To assess the efficacy and safety of the type I interferon receptor antibody, anifrolumab, in patients with active, biopsy-proven, Class III/IV lupus nephritis. Methods This phase II ...

In lupus nephritis(LN), the researchers treated NZB/W lupus mice with a selective histone ... which are activated by several factors and promote the diffusion of urea into the interstitial fluid in ...

However, in urinary tract infections, C3a/C3aR acts protective effect. IgAN, IgA nephropathy; MN, membranous nephropathy; FSGS, focal segmental glomerulosclerosis; LN, lupus nephritis; DKD, diabetic ...

Expert Rev of Obstet Gynecol. 2012;7(3):269-279. In summary, excess levels of urobilinogen and bilirubin in the urine may signal liver disease, and more research is needed to correlate these ...

Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...